|
|
|
|
Call Us at 1-800-766-0884
|
|
|
Studies: Abstracts and Presentations
Over 400 published studies support the basic science behind small pain fiber nerve conduction studies. Presently studies are underway at the University of California at Davis and Irvine (UCD and UCI) and the VA in Long Island and many others. The following studies performed with antecedent devices clearly show this technology is the Gold Standard in detecting pain fiber pathology.
Chronis Prostatitis Causing Pelvic Pain Due To Sacral Entrapment
Pain fiber NCS reveals lumbosacral nerve root lesions associated with prosatitis and pelvic pain syndromes. American College of Surgeons. October 10, 2008.
A-delta Fiber EDX Shows Correlation to VAS Scores
Alex Ambroz, MD Associate Clinical Professor John Marshall University Medical School
A-delta pathology Correlation to Abnormal Vertebral Motion
A Case Study, James L Hedgecock, PhD - AASM-ASEM 5th Annual Conference October 26-27, 2007 Newport Beach, California
A-delta Analysis
Presented at the AASM-ASEM 5th Annual Conference October 26-27, 2007 Newport Beach, California
Predicting Nerve Root Pathology With Small Pain Fiber Nerve Conduction Studies (spf-NCS)
The Axon-II shows 95% sensitivity in detecting pre-DRG pathology.
Using Axon-II to Target Transforamenal Blocks
Summary: Nerve conduction sensory (NCS) test helps to diagnose severity, location & distribution of radiculopathy or neuropathy. Non-invasive method. Measures sensory threshold using neuroselective frequency to test Type A-delta fibers. Abnormally high NCS measures indicate significant nerve conduction loss. Abnormally low NCS indicate hyperesthetic state that corresponds with inflamed, irritated or regenerating nerves.
A-delta EDX Gets to the (Nerve) Root of Fibromyalgia
Summary: Using the Axon-II, LSU Pain Center found the majority of fibromyalgia patients have previously undiagnosed nerve-root pathology. Ten of these treated patients were available for a one-year follow-up. All ten were found free of all fibromyalgia symptoms.
A-delta Analysis Helps Identify Piriformis Syndrome
Summary: This retrospective study of 50 patients found an 80% probability of concomitant piriformis syndrome when the Axon-II detected abnormal L5 and S1 dysfunction on the ipsilatyeral (same) side.
Online Video from American Association of Sensory Electrodiagnostic Medicine (AASEM)
3rd Annual Conference - October 2005 - San Francisco - www.sensorymedicine.org
|
|
|
|
|
|
Sole Distributor and Manufacturer: PainDx, Inc. - Axon-IITM NCSs SystemTM
PHONE: 1-800-766-0884 - E-MAIL: email@nervepathology.com
Home | Learn More | Studies | News | Software | Warnings | Physician Support | Contact Us | Purchase
This website is not for general public use. It is meant for physician reference only.
Nothing presented is meant to represent or imply use other than the FDA Indication and usage.
FDA Indications and Usage: The Axon-IITM NCSs is a diagnostic device that allows the quantitative detection of various sensory neurological impairments caused by various pathological conditions or toxic substance exposures. The subject population for whom this device can be used for diagnostic purposes includes any individual capable of communicating the perception of cutaneous sensation (with the potentiometer, which has a separate FDA clearance, the test is not dependent on the subject reporting perception of the cutaneous sensation, since the action potential of the nerve firing is detectable by the potentiometer). The Axon-IITM NCSs diagnostic examination may be conducted as part the neurological examination or for screening to detect peripheral neuropathies.
Legal Notice
DOCUMENTS
PainDx, Incorporated. gives permission to use documents on this web site provided that:
- The PainDx, Inc. copyright appears in copies and a permission notice appear, © 2010 PainDx, Inc.
- Documents from this site are for informational and non-commercial or personal use only. Such will not be copied or posted to any network computer or broadcast or published in any media or method now or hereafter developed, and
- No modification of any document is made and no unauthorized purpose is prohibited by law. Violation may result in civil and/or criminal penalties.
Materials do not use the design or layout of the website.
INFORMATION ON PAINDX, INCORPORATED'S WEBSITE INCLUDING SPECIFICATIONS, APPEARANCE AND APPLICABILITY MAY BE SUBJECT TO CHANGE WITHOUT NOTICE. NO REPRESENTATIONS ARE MADE OR IMPLIED AS TO THE SUITABILITY OF THE INFORMATION ON THIS SITE FOR ANY PURPOSE. THE FULL CONTENTS ARE PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND AND ARE SUBJECT TO CHANGE WITHOUT NOTICE. ANY TYPE OF RISK WHICH MAY ARISE OUT OF USE OF THIS INFORMATION REMAINS WITH THE RECIPIENT. IN NO EVENT SHALL PAINDX, INCORPORATED BE LIABLE FOR ANY DIRECT, CONSEQUENTIAL, INCIDENTAL, SPECIAL, PUNITIVE OR OTHER DAMAGES (INCLUDING WITHOUT LIMITATION, DAMAGES FOR LOSS OF BUSINESS PROFITS, BUSINESS INTERRUPTION), EVEN IF PAINDX, INCORPORATED HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
TRADEMARK NOTICE
All trademarks displayed on this website are subject to the U.S. trademark law, which support that any unauthorized use of trademarks is strictly prohibited.
Copyright © 2010 PainDx, Inc. - Axon-IITM NCSs SystemTM All Rights Reserved.
|
|
